2-aminoisobutyric acid has been researched along with ng-nitroarginine methyl ester in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Black, KL; Matsukado, K; Nakano, S | 1 |
Chi, OZ; Hunter, C; Liu, X; Weiss, HR | 1 |
2 other study(ies) available for 2-aminoisobutyric acid and ng-nitroarginine methyl ester
Article | Year |
---|---|
Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
Topics: Aminoisobutyric Acids; Animals; Arginine; Blood-Brain Barrier; Blotting, Western; Bradykinin; Brain Neoplasms; Capillary Permeability; Carbon Radioisotopes; Dextrans; Enzyme Inhibitors; Female; Glioma; Immunohistochemistry; Infusions, Intra-Arterial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tumor Cells, Cultured | 1996 |
Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex.
Topics: Administration, Topical; Aminoisobutyric Acids; Animals; Blood Pressure; Blood-Brain Barrier; Carbon Radioisotopes; Cerebral Cortex; Dextrans; Infarction, Middle Cerebral Artery; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tritium; Vascular Endothelial Growth Factor A | 2005 |